Published in Heart Lung on March 21, 2011
Elevated Plasma Matrix Metalloproteinase-9 and Its Correlations with Severity of Disease in Patients with Ventilator-Associated Pneumonia. Int J Med Sci (2016) 0.75
BreathDx - molecular analysis of exhaled breath as a diagnostic test for ventilator-associated pneumonia: protocol for a European multicentre observational study. BMC Pulm Med (2017) 0.75
Diagnostic Performance of Soluble Triggering Receptor Expressed on Myeloid Cells-1 in Ventilator-Associated Pneumonia of Patients with Ischemic Stroke. Can J Infect Dis Med Microbiol (2017) 0.75
C-reactive protein: a critical update. J Clin Invest (2003) 11.77
Ventilator-associated pneumonia. Am J Respir Crit Care Med (2002) 9.63
Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial. Lancet (2010) 7.61
Epidemiology and outcomes of ventilator-associated pneumonia in a large US database. Chest (2002) 6.13
Cutting edge: inflammatory responses can be triggered by TREM-1, a novel receptor expressed on neutrophils and monocytes. J Immunol (2000) 5.37
TREM-1 amplifies inflammation and is a crucial mediator of septic shock. Nature (2001) 5.24
Clinical and economic consequences of ventilator-associated pneumonia: a systematic review. Crit Care Med (2005) 4.03
Invasive and noninvasive strategies for management of suspected ventilator-associated pneumonia. A randomized trial. Ann Intern Med (2000) 3.89
Guidelines for preventing health-care--associated pneumonia, 2003: recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee. MMWR Recomm Rep (2004) 3.84
Diagnosis of ventilator-associated pneumonia by bacteriologic analysis of bronchoscopic and nonbronchoscopic "blind" bronchoalveolar lavage fluid. Am Rev Respir Dis (1991) 3.79
A soluble form of the triggering receptor expressed on myeloid cells-1 modulates the inflammatory response in murine sepsis. J Exp Med (2004) 2.80
The attributable morbidity and mortality of ventilator-associated pneumonia in the critically ill patient. The Canadian Critical Trials Group. Am J Respir Crit Care Med (1999) 2.69
Value of the clinical pulmonary infection score for the identification and management of ventilator-associated pneumonia. Intensive Care Med (2004) 1.91
Implications of endotracheal tube biofilm for ventilator-associated pneumonia. Intensive Care Med (1999) 1.86
C-reactive protein: a valuable marker of sepsis. Intensive Care Med (2002) 1.82
Diagnostic implications of soluble triggering receptor expressed on myeloid cells-1 in BAL fluid of patients with pulmonary infiltrates in the ICU. Chest (2008) 1.81
Diagnosing pneumonia during mechanical ventilation: the clinical pulmonary infection score revisited. Am J Respir Crit Care Med (2003) 1.79
Soluble Triggering Receptor Expressed on Myeloid cells-1 in bronchoalveolar lavage fluid is not predictive for ventilator-associated pneumonia. Intensive Care Med (2009) 1.66
TREM-1, MDL-1, and DAP12 expression is associated with a mature stage of myeloid development. Mol Immunol (2002) 1.58
Physiology and genetics of procalcitonin. Physiol Res (2000) 1.53
Alveolar and serum procalcitonin: diagnostic and prognostic value in ventilator-associated pneumonia. Anesthesiology (2002) 1.49
C-reactive protein as a marker of ventilator-associated pneumonia resolution: a pilot study. Eur Respir J (2005) 1.49
Serial changes in soluble triggering receptor expressed on myeloid cells in the lung during development of ventilator-associated pneumonia. Intensive Care Med (2005) 1.48
Tracheal tube biofilm as a source of bacterial colonization of the lung. J Clin Microbiol (1989) 1.46
Effect of ventilator-associated pneumonia on mortality and morbidity. Am J Respir Crit Care Med (1996) 1.46
C-reactive protein as a marker of infection in critically ill patients. Clin Microbiol Infect (2005) 1.43
Usefulness of procalcitonin for the diagnosis of ventilator-associated pneumonia. Intensive Care Med (2008) 1.31
Sequential measurements of procalcitonin levels in diagnosing ventilator-associated pneumonia. Eur Respir J (2007) 1.28
Soluble form of the triggering receptor expressed on myeloid cells-1 as a marker of microbial infection. Clin Med Res (2004) 1.22
Effect of procalcitonin-guided treatment in patients with infections: a systematic review and meta-analysis. Infection (2009) 1.21
Clinical pulmonary infection score for ventilator-associated pneumonia: accuracy and inter-observer variability. Intensive Care Med (2003) 1.18
Soluble triggering receptor expressed on myeloid cell-1 is increased in patients with ventilator-associated pneumonia: a preliminary report. Chest (2007) 1.12
Diagnostic utility of the soluble triggering receptor expressed on myeloid cells-1 in bronchoalveolar lavage fluid from patients with bilateral lung infiltrates. Crit Care (2008) 1.08
Antibiotic treatment interruption of suspected lower respiratory tract infections based on a single procalcitonin measurement at hospital admission--a randomized trial. Clin Microbiol Infect (2009) 1.06
The futility of the clinical pulmonary infection score in trauma patients. J Trauma (2006) 1.06
Triggering receptor expressed on myeloid cells-1 expression on monocytes is associated with inflammation but not with infection in acute pancreatitis. Crit Care (2009) 1.03
Serum markers in community-acquired pneumonia and ventilator-associated pneumonia. Curr Opin Infect Dis (2008) 1.01
Soluble TREM-1 is not suitable for distinguishing between systemic inflammatory response syndrome and sepsis survivors and nonsurvivors in the early stage of acute inflammation. Eur J Anaesthesiol (2009) 0.97
Elevations in procalcitonin but not C-reactive protein are associated with pneumonia after cardiopulmonary resuscitation. Resuscitation (2002) 0.96
Production of soluble triggering receptor expressed on myeloid cells by lipopolysaccharide-stimulated human neutrophils involves de novo protein synthesis. Clin Vaccine Immunol (2006) 0.95
Ventilator-associated pneumonia or not? Contemporary diagnosis. Emerg Infect Dis (2001) 0.87
Appraisal of recommended respiratory infection control practices in primary care and emergency department settings. Am J Infect Control (2008) 0.92
Triggering receptor expressed on myeloid cells type 1 as a potential therapeutic target in sepsis. Dimens Crit Care Nurs (2011) 0.83
Educational competencies to strengthen tuberculosis curricula in undergraduate nursing programs. Int J Nurs Educ Scholarsh (2006) 0.81
Personal healthcare worker (HCW) and work-site characteristics that affect HCWs' use of respiratory-infection control measures in ambulatory healthcare settings. Infect Control Hosp Epidemiol (2009) 0.76
Fitness support group for organ transplant recipients: self-management, self-efficacy and health status. J Adv Nurs (2009) 0.75
Development of the American association of critical-care nurses' sedation assessment scale for critically ill patients. Am J Crit Care (2005) 0.75
Clinical nurse specialists and nurse practitioners: complementary roles for infectious disease and infection control. Am J Infect Control (2004) 0.75
Tuberculosis education for nurse practitioner students: where we are and where we need to go. J Nurs Educ (2009) 0.75